The Effect of Eszopiclone on the Arousal Threshold in Sleep Apnea Syndrome
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether taking eszopiclone (Lunesta) changes the
breathing effort required to briefly wake people with obstructive sleep apnea from sleep
(respiratory arousal threshold). We would like to see if taking eszopiclone can reduce the
severity of obstructive sleep apnea in some people (those that have a low respiratory arousal
threshold; i.e. wake up easily to respiratory stimuli).
Phase:
Early Phase 1
Details
Lead Sponsor:
Brigham and Women's Hospital
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI) National Institutes of Health (NIH) Sunovion